Hangzhou Bangshun Pharmaceutical Co., Ltd.
PrivateLast Round
Series C
Dec 1, 2025
Est. Valuation
$334.18M
Total Funding Raised
$52.78M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Hangzhou Bangshun Pharmaceutical Co., Ltd. is a biotechnology company that focuses on the discovery, development, and commercialization of innovative therapies for oncology and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hangzhou Bangshun Pharmaceutical Co., Ltd. Comparables
Compare Hangzhou Bangshun Pharmaceutical Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Suzhou Zelgen Biopharmaceuticals Co Ltd | 81% | |
| Sino Biopharmaceutical | 81% | |
| InnoCare Pharma Limited | 78% |
Hangzhou Bangshun Pharmaceutical Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Dec 1, 2025 | ||||
| Series B Extension | Aug 27, 2025 | ||||
| Series B Extension | May 1, 2025 | ||||
| Series B Extension | Oct 12, 2023 | ||||
| Series B | Jan 9, 2023 | ||||
Series A | Dec 1, 2021 |
Hangzhou Bangshun Pharmaceutical Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Jiaming Haochun | Series B |
| Delta Capital | Series B |
| Puhua Capital | Series A, Seed |
| Shenzhen Capital Group | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 1, 2025
$12.2M round raised with multiple investors.
- Aug 27, 2025
Raised $6M in a Series B Extension round.
Hangzhou Bangshun Pharmaceutical Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Hangzhou Bangshun Pharmaceutical Co., Ltd.'s valuation, stock price, and market status.
Is Hangzhou Bangshun Pharmaceutical Co., Ltd. a public or private company?
Hangzhou Bangshun Pharmaceutical Co., Ltd. is a private company.
What is the current stock price of Hangzhou Bangshun Pharmaceutical Co., Ltd.?
Hangzhou Bangshun Pharmaceutical Co., Ltd. is a private company with no public stock price. Caplight tracks Hangzhou Bangshun Pharmaceutical Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Hangzhou Bangshun Pharmaceutical Co., Ltd. worth (valuation)?
Hangzhou Bangshun Pharmaceutical Co., Ltd.'s valuation is estimated at $334.2M based on funding round data.
Can I buy Hangzhou Bangshun Pharmaceutical Co., Ltd. stock?
Hangzhou Bangshun Pharmaceutical Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Hangzhou Bangshun Pharmaceutical Co., Ltd.'s last funding round?
Hangzhou Bangshun Pharmaceutical Co., Ltd.'s most recent funding round was Series C on December 1, 2025.
Who are the main investors in Hangzhou Bangshun Pharmaceutical Co., Ltd.?
Key investors in Hangzhou Bangshun Pharmaceutical Co., Ltd. include Puhua Capital, Shenzhen Capital Group.
Will Hangzhou Bangshun Pharmaceutical Co., Ltd. IPO soon?
No public IPO plans have been announced for Hangzhou Bangshun Pharmaceutical Co., Ltd..
How can I track Hangzhou Bangshun Pharmaceutical Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Hangzhou Bangshun Pharmaceutical Co., Ltd.'s secondary market activity and sign up for updates.